Testing effectiveness (Phase 2)Study completedNCT00354549
What this trial is testing
Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLC
Who this might be right for
Lung Cancer
Swiss Cancer Institute 104